JPMorgan Chase & Co’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-419,221
| Closed | -$25.1M | – | 4983 |
|
|
2019
Q4 | $25.1M | Buy |
419,221
+289,319
| +223% | +$17.3M | ﹤0.01% | 1229 |
|
|
2019
Q3 | $3.65M | Buy |
129,902
+6,006
| +5% | +$169K | ﹤0.01% | 2385 |
|
|
2019
Q2 | $4.61M | Sell |
123,896
-4,370
| -3% | -$163K | ﹤0.01% | 2172 |
|
|
2019
Q1 | $5.01M | Buy |
128,266
+7,114
| +6% | +$278K | ﹤0.01% | 2099 |
|
|
2018
Q4 | $2.58M | Buy |
121,152
+3,868
| +3% | +$82.5K | ﹤0.01% | 2508 |
|
|
2018
Q3 | $4.64M | Buy |
117,284
+3,331
| +3% | +$132K | ﹤0.01% | 2287 |
|
|
2018
Q2 | $4.35M | Sell |
113,953
-788
| -0.7% | -$30.1K | ﹤0.01% | 2331 |
|
|
2018
Q1 | $3.45M | Sell |
114,741
-7,403
| -6% | -$222K | ﹤0.01% | 2440 |
|
|
2017
Q4 | $3.82M | Buy |
122,144
+44,944
| +58% | +$1.4M | ﹤0.01% | 2414 |
|
|
2017
Q3 | $2.29M | Sell |
77,200
-6,805
| -8% | -$202K | ﹤0.01% | 2567 |
|
|
2017
Q2 | $1.61M | Sell |
84,005
-25,920
| -24% | -$496K | ﹤0.01% | 2702 |
|
|
2017
Q1 | $1.87M | Sell |
109,925
-13,915
| -11% | -$237K | ﹤0.01% | 2637 |
|
|
2016
Q4 | $2.26M | Sell |
123,840
-6,726
| -5% | -$123K | ﹤0.01% | 2597 |
|
|
2016
Q3 | $2.33M | Buy |
+130,566
| New | +$2.33M | ﹤0.01% | 2386 |
|